A Camden, New Jersey, federal judge ruled that Teva Pharmaceuticals USA Inc.'s application to make a generic version of a drug called Korlym did not infringe on patents on the drug that are held by ...

With the rapid introduction of novel breast cancer therapies, recognizing and managing side effects is essential to maintain adherence and improve outcomes. As novel oral endocrine therapies and ...

An interview with Dr. Harold Burstein from Dana Farber Cancer Institute in Boston, MA, chair on “Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast ...

June 2 (Reuters) - AstraZeneca (AZN.L), opens new tab and Daiichi Sankyo's (4568.T), opens new tab Enhertu slows the progression of breast cancer by about five months in women whose disease worsened ...

WASHINGTON—R. Scott Struthers, Ph.D., has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for his contributions to drug discovery and development programs for endocrine ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women receiving endocrine therapy for hormone receptor (HR)-positive breast cancer or its ...

Joint Press Release from the European Society of Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) and the Armenian Association of Paediatric Endocrinologists and the ...

Despite major advances in oncology, drug resistance remains one of the principal obstacles to achieving durable responses and cure in cancer patients. Both ...

A new Scientific Statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system. The use and misuse of opioids is ...

Diagnosis of drug-induced adrenal insufficiency (AI) continues to pose challenges to clinicians, not only due to nonspecific presenting symptoms but also due to the increasing list of drugs that ...